This inventor holds 2 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Innovations of Kenneth A. Lord
Introduction
Kenneth A. Lord is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods and diagnostic assays.
Latest Patents
Kenneth A. Lord holds 2 patents. His latest patents include the discovery of human protein kinases hYAK3-2, which involves polypeptides and polynucleotides. These innovations detail methods for producing such polypeptides through recombinant techniques. Furthermore, they outline applications for treating various conditions, including bone loss, inflammatory diseases, infections, cancers, and neurological disorders. Another patent focuses on EPRG3Spt polypeptides and polynucleotides, which also have therapeutic and diagnostic applications.
Career Highlights
Kenneth A. Lord is associated with SmithKline Beecham Corporation, where he has contributed to groundbreaking research and development in his field. His work has implications for a wide range of medical conditions, showcasing his commitment to advancing healthcare solutions.
Collaborations
Some of his notable coworkers include Susan B. Dillon and Caretha Lee Creasy, who have collaborated with him on various projects, enhancing the impact of their research.
Conclusion
Kenneth A. Lord's innovative work in biotechnology has led to significant advancements in therapeutic methods and diagnostic tools, making him a key figure in his field.